BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caragher S, Chalmers AJ, Gomez-Roman N. Glioblastoma's Next Top Model: Novel Culture Systems for Brain Cancer Radiotherapy Research. Cancers (Basel) 2019;11:E44. [PMID: 30621226 DOI: 10.3390/cancers11010044] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Riedel A, Klumpp L, Menegakis A, De-Colle C, Huber SM, Schittenhelm J, Neumann M, Noell S, Tatagiba M, Zips D. γH2AX foci assay in glioblastoma: Surgical specimen versus corresponding stem cell culture. Radiother Oncol 2021;159:119-25. [PMID: 33775712 DOI: 10.1016/j.radonc.2021.03.023] [Reference Citation Analysis]
2 Cornelison RC, Yuan JX, Tate KM, Petrosky A, Beeghly GF, Bloomfield M, Schwager SC, Berr AL, Stine CA, Cimini D, Bafakih FF, Mandell JW, Purow BW, Horton BJ, Munson JM. A patient-designed tissue-engineered model of the infiltrative glioblastoma microenvironment. NPJ Precis Oncol 2022;6:54. [PMID: 35906273 DOI: 10.1038/s41698-022-00290-8] [Reference Citation Analysis]
3 Nikolakopoulou P, Rauti R, Voulgaris D, Shlomy I, Maoz BM, Herland A. Recent progress in translational engineered in vitro models of the central nervous system. Brain 2020;143:3181-213. [PMID: 33020798 DOI: 10.1093/brain/awaa268] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
4 Li Z, Langhans SA. In Vivo and Ex Vivo Pediatric Brain Tumor Models: An Overview. Front Oncol 2021;11:620831. [PMID: 33869004 DOI: 10.3389/fonc.2021.620831] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lovett ML, Nieland TJF, Dingle YL, Kaplan DL. Innovations in 3-Dimensional Tissue Models of Human Brain Physiology and Diseases. Adv Funct Mater 2020;30:1909146. [PMID: 34211358 DOI: 10.1002/adfm.201909146] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
6 Sharifzad F, Yasavoli‐sharahi H, Mardpour S, Fakharian E, Nikuinejad H, Heydari Y, Mardpour S, Taghikhani A, khellat R, Vafaei S, Kiani S, Ghavami S, Łos M, Noureddini M, Ebrahimi M, Verdi J, Hamidieh AA. Neuropathological and genomic characterization of glioblastoma‐induced rat model: How similar is it to humans for targeted therapy? J Cell Physiol 2019;234:22493-504. [DOI: 10.1002/jcp.28813] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
7 Dorrell MI, Kast-Woelbern HR, Botts RT, Bravo SA, Tremblay JR, Giles S, Wada JF, Alexander M, Garcia E, Villegas G, Booth CB, Purington KJ, Everett HM, Siles EN, Wheelock M, Silva JA, Fortin BM, Lowey CA, Hale AL, Kurz TL, Rusing JC, Goral DM, Thompson P, Johnson AM, Elson DJ, Tadros R, Gillette CE, Coopwood C, Rausch AL, Snowbarger JM. A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis. PLoS One 2021;16:e0252233. [PMID: 34077449 DOI: 10.1371/journal.pone.0252233] [Reference Citation Analysis]
8 Paolillo M, Comincini S, Schinelli S. In Vitro Glioblastoma Models: A Journey into the Third Dimension. Cancers (Basel) 2021;13:2449. [PMID: 34070023 DOI: 10.3390/cancers13102449] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lange F, Hörnschemeyer J, Kirschstein T. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy. Cells 2021;10:1226. [PMID: 34067762 DOI: 10.3390/cells10051226] [Reference Citation Analysis]
10 Nehra M, Uthappa UT, Kumar V, Kumar R, Dixit C, Dilbaghi N, Mishra YK, Kumar S, Kaushik A. Nanobiotechnology-assisted therapies to manage brain cancer in personalized manner. J Control Release 2021;338:224-43. [PMID: 34418523 DOI: 10.1016/j.jconrel.2021.08.027] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ustun M, Rahmani Dabbagh S, Ilci IS, Bagci-Onder T, Tasoglu S. Glioma-on-a-Chip Models. Micromachines (Basel) 2021;12:490. [PMID: 33926127 DOI: 10.3390/mi12050490] [Reference Citation Analysis]
12 Langhans SA. Using 3D in vitro cell culture models in anti-cancer drug discovery. Expert Opin Drug Discov 2021;16:841-50. [PMID: 33823728 DOI: 10.1080/17460441.2021.1912731] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Shin K, Shin H, Cho HJ, Kang H, Lee JK, Seo YJ, Shin YJ, Kim D, Koo H, Kong DS, Seol HJ, Lee JI, Lee HW, Nam DH. Sphere-Forming Culture for Expanding Genetically Distinct Patient-Derived Glioma Stem Cells by Cellular Growth Rate Screening. Cancers (Basel) 2020;12:E549. [PMID: 32120790 DOI: 10.3390/cancers12030549] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Fanfone D, Idbaih A, Mammi J, Gabut M, Ichim G. Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres. Cancers (Basel) 2020;12:E2853. [PMID: 33023187 DOI: 10.3390/cancers12102853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
15 Almengló C, Caamaño P, Fraga M, Devesa J, Costoya JA, Arce VM. From neural stem cells to glioblastoma: A natural history of GBM recapitulated in vitro. J Cell Physiol 2021. [PMID: 33959982 DOI: 10.1002/jcp.30409] [Reference Citation Analysis]
16 Lenin S, Ponthier E, Scheer KG, Yeo ECF, Tea MN, Ebert LM, Oksdath Mansilla M, Poonnoose S, Baumgartner U, Day BW, Ormsby RJ, Pitson SM, Gomez GA. A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma. Int J Mol Sci 2021;22:4322. [PMID: 33919246 DOI: 10.3390/ijms22094322] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Dubey SK, Pradyuth SK, Saha RN, Singhvi G, Alexander A, Agrawal M, Shapiro BA, Puri A. Application of photodynamic therapy drugs for management of glioma. J Porphyrins Phthalocyanines 2019;23:1216-28. [DOI: 10.1142/s1088424619300192] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Sivakumar H, Devarasetty M, Kram DE, Strowd RE, Skardal A. Multi-Cell Type Glioblastoma Tumor Spheroids for Evaluating Sub-Population-Specific Drug Response. Front Bioeng Biotechnol 2020;8:538663. [PMID: 33042963 DOI: 10.3389/fbioe.2020.538663] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
19 Jin F, Jin-lee HJ, Johnson AJ. Mouse Models of Experimental Glioblastoma. In: Debinski W, editor. Gliomas. Exon Publications; 2021. pp. 15-46. [DOI: 10.36255/exonpublications.gliomas.2021.chapter2] [Reference Citation Analysis]
20 Rominiyi O, Al-Tamimi Y, Collis SJ. The 'Ins and Outs' of Early Preclinical Models for Brain Tumor Research: Are They Valuable and Have We Been Doing It Wrong? Cancers (Basel) 2019;11:E426. [PMID: 30934632 DOI: 10.3390/cancers11030426] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
21 Bikhezar F, de Kruijff RM, van der Meer AJGM, Torrelo Villa G, van der Pol SMA, Becerril Aragon G, Gasol Garcia A, Narayan RS, de Vries HE, Slotman BJ, Denkova AG, Sminia P. Preclinical evaluation of binimetinib (MEK162) delivered via polymeric nanocarriers in combination with radiation and temozolomide in glioma. J Neurooncol 2020;146:239-46. [PMID: 31875307 DOI: 10.1007/s11060-019-03365-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
22 Menezes WP, Silva VAO, Gomes INF, Rosa MN, Spina MLC, Carloni AC, Alves ALV, Melendez M, Almeida GC, Silva LSD, Clara C, da Cunha IW, Hajj GNM, Jones C, Bidinotto LT, Reis RM. Loss of 5'-Methylthioadenosine Phosphorylase (MTAP) is Frequent in High-Grade Gliomas; Nevertheless, it is Not Associated with Higher Tumor Aggressiveness. Cells 2020;9:E492. [PMID: 32093414 DOI: 10.3390/cells9020492] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
23 Merrick M, Mimlitz MJ, Weeder C, Akhter H, Bray A, Walther A, Nwakama C, Bamesberger J, Djam H, Abid K, Ekpenyong A. In vitro radiotherapy and chemotherapy alter migration of brain cancer cells before cell death. Biochem Biophys Rep 2021;27:101071. [PMID: 34286111 DOI: 10.1016/j.bbrep.2021.101071] [Reference Citation Analysis]
24 Schmitt C, Adamski V, Rasch F, Adelung R, Lucius R, Synowitz M, Hattermann K, Held-feindt J. Establishment of a glioblastoma in vitro (in)complete resection dual co-culture model suitable for drug testing. Annals of Anatomy - Anatomischer Anzeiger 2020;228:151440. [DOI: 10.1016/j.aanat.2019.151440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Pamies D, Zurich MG, Hartung T. Organotypic Models to Study Human Glioblastoma: Studying the Beast in Its Ecosystem. iScience 2020;23:101633. [PMID: 33103073 DOI: 10.1016/j.isci.2020.101633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Rominiyi O, Collis SJ. DDRugging glioblastoma: understanding and targeting the DNA damage response to improve future therapies. Mol Oncol 2021. [PMID: 34036721 DOI: 10.1002/1878-0261.13020] [Reference Citation Analysis]
27 Engwer C, Wenske M. Estimating the extent of glioblastoma invasion : Approximate stationalization of anisotropic advection-diffusion-reaction equations in the context of glioblastoma invasion. J Math Biol 2021;82:10. [PMID: 33496806 DOI: 10.1007/s00285-021-01563-9] [Reference Citation Analysis]
28 Liu P, Griffiths S, Veljanoski D, Vaughn-Beaucaire P, Speirs V, Brüning-Richardson A. Preclinical models of glioblastoma: limitations of current models and the promise of new developments. Expert Rev Mol Med 2021;23:e20. [PMID: 34852856 DOI: 10.1017/erm.2021.20] [Reference Citation Analysis]
29 Witusik-Perkowska M, Jaskólski DJ, Liberski PP, Szemraj J. If Artificial In Vitro Microenvironment Can Influence Tumor Drug Resistance Network via Modulation of lncRNA Expression?-Comparative Analysis of Glioblastoma-Derived Cell Culture Models and Initial Tumors In Vivo. Cell Mol Neurobiol 2020. [PMID: 33245508 DOI: 10.1007/s10571-020-00991-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Carmell N, Rominiyi O, Myers KN, McGarrity-Cottrell C, Vanderlinden A, Lad N, Perroux-David E, El-Khamisy SF, Fernando M, Finegan KG, Brown S, Collis SJ. Identification and Validation of ERK5 as a DNA Damage Modulating Drug Target in Glioblastoma. Cancers (Basel) 2021;13:944. [PMID: 33668183 DOI: 10.3390/cancers13050944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Chaudhary P, Milluzzo G, Ahmed H, Odlozilik B, Mcmurray A, Prise KM, Borghesi M. Radiobiology Experiments With Ultra-high Dose Rate Laser-Driven Protons: Methodology and State-of-the-Art. Front Phys 2021;9:624963. [DOI: 10.3389/fphy.2021.624963] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
32 Kazmi F, Vallis KA, Vellayappan BA, Bandla A, Yukun D, Carlisle R. Megavoltage Radiosensitization of Gold Nanoparticles on a Glioblastoma Cancer Cell Line Using a Clinical Platform. Int J Mol Sci 2020;21:E429. [PMID: 31936587 DOI: 10.3390/ijms21020429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
33 Caragher S, Miska J, Shireman J, Park CH, Muroski M, Lesniak MS, Ahmed AU. Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells. Cancers (Basel) 2020;12:E3126. [PMID: 33114573 DOI: 10.3390/cancers12113126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
34 Stackhouse CT, Rowland JR, Shevin RS, Singh R, Gillespie GY, Willey CD. A Novel Assay for Profiling GBM Cancer Model Heterogeneity and Drug Screening. Cells 2019;8:E702. [PMID: 31336733 DOI: 10.3390/cells8070702] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Gattas MJ, Estecho IG, Lago Huvelle MA, Errasti AE, Carrera Silva EA, Simian M. A Heterotypic Tridimensional Model to Study the Interaction of Macrophages and Glioblastoma In Vitro. Int J Mol Sci 2021;22:5105. [PMID: 34065977 DOI: 10.3390/ijms22105105] [Reference Citation Analysis]